Kellogg on biotechnology : thriving through integration /
Kellogg on biotechnology : thriving through integration /
edited by Alicia Löffler.
- Evanston, Ill. : London : Northwestern University Press : Kellogg School of Management ; Kogan Page, c2005.
- xiii, 264 p. : ill. ; 23 cm.
Includes bibliographical references and index.
Contents
Part I: Emerging Technologies: The Fuel of Biotechnology,
1 Promises and Challenges of the U.S. Stem Cell Industry,
Whit Alexander and Shail Thaker
2 Pharmacogenomics: Overcoming the Hurdles to Adoption,
Janette Chung, Peggy Mathias, and Rebecca Wildman
3 Nanobiotechnology: Applications and Commercialization Strategies,
Badri Amurthur, Barry Grant, Markus Hildinger, Eric Hyllengren,
Mohammed Ladha, Michael Masters, Daniel Shuffrin, and Jing Ye
Part II: The Business of Science: Enhancing the Value of the Innovations
through the Perfect Business Model,
4 Sustaining Platforms,
Erich Hoefer, Sriram Jambunathan, Anne Tse, and Mariona Vincens
5 Mergers and Acquisitions as a Strategic Alternative in Biotech,
Andrew Ingley, Gregory Lief, and Jeanne Lukacek
Part III: The Home Stretch: Commercializing and Capturing the Value of
the Innovation,
6 Biologics Manufacturing: The Make or Buy Decision,
Anurag Bagaria
7 Pharming Factories,
Andrew Ingley, James Pavlik, and Ty Smith
8 The Role of Marketing,
Dario Benavides, Lanier Coles, Gary Dulaney, Vanessa Rath, and Carla
Yarger
9 To DTC or Not to DTC: Direct-to-Consumer Marketing in Medical
Devices,
Roy Katz, Edna Lazar, Christopher Pfaff, and Thomas Walsh
10 The Forgotten Issue: Reimbursement in Biotechnology,
Raj Changrani, William Gangi, Alice Manard, Seung Sohn, and Steven
Stark
0810122278 (pbk. : alk. paper)
Biotechnology.
Biotechnology industries.
Biomedical Technology.
Biotechnology--economics.
Biotechnology--organization & administration.
Technology, Pharmaceutical.
W 82 K29 2005 / K29 2005
Includes bibliographical references and index.
Contents
Part I: Emerging Technologies: The Fuel of Biotechnology,
1 Promises and Challenges of the U.S. Stem Cell Industry,
Whit Alexander and Shail Thaker
2 Pharmacogenomics: Overcoming the Hurdles to Adoption,
Janette Chung, Peggy Mathias, and Rebecca Wildman
3 Nanobiotechnology: Applications and Commercialization Strategies,
Badri Amurthur, Barry Grant, Markus Hildinger, Eric Hyllengren,
Mohammed Ladha, Michael Masters, Daniel Shuffrin, and Jing Ye
Part II: The Business of Science: Enhancing the Value of the Innovations
through the Perfect Business Model,
4 Sustaining Platforms,
Erich Hoefer, Sriram Jambunathan, Anne Tse, and Mariona Vincens
5 Mergers and Acquisitions as a Strategic Alternative in Biotech,
Andrew Ingley, Gregory Lief, and Jeanne Lukacek
Part III: The Home Stretch: Commercializing and Capturing the Value of
the Innovation,
6 Biologics Manufacturing: The Make or Buy Decision,
Anurag Bagaria
7 Pharming Factories,
Andrew Ingley, James Pavlik, and Ty Smith
8 The Role of Marketing,
Dario Benavides, Lanier Coles, Gary Dulaney, Vanessa Rath, and Carla
Yarger
9 To DTC or Not to DTC: Direct-to-Consumer Marketing in Medical
Devices,
Roy Katz, Edna Lazar, Christopher Pfaff, and Thomas Walsh
10 The Forgotten Issue: Reimbursement in Biotechnology,
Raj Changrani, William Gangi, Alice Manard, Seung Sohn, and Steven
Stark
0810122278 (pbk. : alk. paper)
Biotechnology.
Biotechnology industries.
Biomedical Technology.
Biotechnology--economics.
Biotechnology--organization & administration.
Technology, Pharmaceutical.
W 82 K29 2005 / K29 2005